Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 251,247 | 159,201 | 81,321 | 50,286 | 26,551 |
| Cost of Goods | 5,215 | 3,554 | 2,058 | 1,361 | 882 |
| Gross Profit | 246,032 | 155,647 | 79,263 | 48,925 | 25,669 |
| Operating Expenses | 156,751 | 103,346 | 69,142 | 52,729 | 54,170 |
| Operating Income | 89,496 | 52,855 | 10,179 | -3,443 | -27,619 |
| Interest Expense | 0 | 0 | 0 | 2,965 | 3,764 |
| Other Income | 2,657 | -49 | -2,039 | 0 | 0 |
| Pre-tax Income | 92,153 | 52,806 | 8,140 | -6,408 | -31,383 |
| Income Tax | 16,743 | -76,316 | N/A | N/A | N/A |
| Net Income Continuous | 75,410 | 129,122 | 8,140 | -6,408 | -31,383 |
| Net Income | $75,410 | $129,122 | $8,140 | $-6,408 | $-31,383 |
| EPS Basic Total Ops | 0.65 | 1.14 | 0.07 | -0.06 | -0.31 |
| EPS Basic Continuous Ops | 0.65 | 1.14 | 0.07 | -0.06 | -0.31 |
| EPS Diluted Total Ops | 0.60 | 1.04 | 0.07 | -0.06 | -0.31 |
| EPS Diluted Continuous Ops | 0.60 | 1.04 | 0.07 | -0.06 | -0.31 |
| EPS Diluted Before Non-Recurring Items | 0.60 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $88,011 | $52,975 | $10,287 | $-3,266 | $-27,449 |